Could a digital tool help sarcoma patients handle treatment side effects?
NCT ID NCT06211257
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a digital personalized care plan (ePCP) can help people with advanced sarcoma who are on chemotherapy. About 377 participants will either get the digital plan plus standard care, or standard care alone. The main goal is to see if the digital tool reduces severe side effects in the first three months of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- digital personalized care plan (ePCP)
- What this could lead to
- If it works, this could improve how patients manage severe side effects from sarcoma treatment, making their experience less difficult.
- What could go wrong
- This is a non-drug intervention, so the benefit may be small or hard to measure. The trial is still recruiting and results are not yet available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Jean Minjoz
RECRUITINGBesançon, Bourgogne-Franche-Comté, 25000, France
-
CHU de Poitiers
RECRUITINGPoitiers, New Aquitaine, 86021, France
-
Centre Eugène Marquis
NOT_YET_RECRUITINGRennes, Brittany Region, 35042, France
-
Centre Léon Bérard
RECRUITINGLyon, Auvergne-Rhône-Alpes, 69373, France
-
Centre Oscar Lambret
RECRUITINGLille, Hauts-de-France, 59020, France
-
Centre Paul Strauss
RECRUITINGStrasbourg, Grand Est, 67033, France
-
Gustave Roussy
RECRUITINGVillejuif, Île-de-France Region, 94800, France
-
Hôpital Pitié-Salpêtrière AP-HP
NOT_YET_RECRUITINGParis, Île-de-France Region, 75013, France
-
Institut Claudius Regaud
WITHDRAWNToulouse, Occitanie, 31059, France
-
Institut de Cancérologie de Lorraine
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, 54519, France
-
Institut de Cancérologie de l'Ouest
RECRUITINGSaint-Herblain, Pays de la Loire Region, 44805, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glow-in-the-Dark dye could help surgeons spot hidden sarcoma tumors in Children's lungs
- Could early palliative care reduce aggressive End-of-Life cancer treatments?
- New Drug-Coated membrane targets sarcoma after surgery
- New drug trial aims to slow rare Cancer's spread
- Could a diabetes drug help fight sarcoma? new trial explores metformin's potential
- New cocktail of drugs and radiation takes on Hard-to-Treat sarcoma